Pivotal role of convalescent plasma in managing emerging infectious diseases
- PMID: 32240549
- PMCID: PMC7228342
- DOI: 10.1111/vox.12927
Pivotal role of convalescent plasma in managing emerging infectious diseases
Figures
References
-
- WHO : Ten threats to global health in 2019. https://www.who.int/emergencies/ten‐threats‐to‐global‐health‐in‐2019 (Last accessed 13/01/2020).
-
- Bozzo J, Jorquera JI: Use of human immunoglobulins as an anti‐infective treatment: the experience so far and their possible re‐emerging role. Expert Rev Anti Infect Ther 2017; 15:585–604 - PubMed
-
- WHO : Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. Interim guidance for national health authorities and blood transfusion services. 2014. http://apps.who.int/iris/bitstream/10665/135591/1/WHO_HIS_SDS_2014.8_eng... (Last accessed.
-
- Chen L, Xiong J, Bao L, et al.: Convalescent plasma as a potential therapy for COVID‐19. Lancet Infect Dis 2020. https://10.1016/S1473‐3099(20)30141‐9 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources